FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
632 letters match. Newest first.
-
DrugsDrivergent, Inc.
Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.
High risk -
DrugsPremier Nutra Pharma Inc.
FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.
High risk -
DrugsAccra-Pac, Inc. dba Voyant Beauty
Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.
High risk -
DrugsPharmaplast S.A.E.
FDA cited Pharmaplast S.A.E. for failing to test drug components, including glycerin and ethanol, for dangerous contaminants.
High risk -
DrugsZermat International S.A. de C.V.
FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.
High risk -
DrugsChemical Services Group, Inc./Royal Chemical Company
Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.
High risk -
DrugsEco Lips, Inc.
FDA warned Eco Lips, Inc. that its over-the-counter sunscreen drug products had serious manufacturing and testing failures.
High risk -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
Champaklal Maganlal Homeo Pharmacy failed to test each glycerin lot for identity, including DEG/EG, in OTC and homeopathic drugs.
High risk -
DrugsOmega Packaging Corp
Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.
High risk -
DrugsNuGeneration Technologies LLC
FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.
High risk -
DrugsCosmetic Science Laboratories LLC
FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.
High risk -
DrugsDunagin Pharmaceuticals Inc. dba Massco Dental
Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.
High risk -
DrugsFormology Lab Inc.
FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.
High risk -
DrugsMidlab Incorporated
FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.
High risk -
DrugsFrenda Corporation
FDA found Frenda made OTC alcohol and hand sanitizer under insanitary conditions with industrial chemical cross-contamination risk.
High risk -
DrugsProfounda, Inc.
FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.
High risk -
DrugsAtlantic Management Resources LTD dba. Claire Ellen Products
Atlantic Management Resources (Claire Ellen Products) had CGMP violations and distributed unlisted Neuroquell Plus Cream.
Medium -
DrugsB & J Group
B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.
High risk -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsUltra Chem Labs Corporation
FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.
High risk -
DrugsClean Cosmetics LLC
FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.
High risk -
DrugsSalon Technologies International, Inc.
FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.
High risk -
DrugsQuality Supplement Manufacturing, Inc.
FDA cited Quality Supplement Manufacturing for dietary supplement manufacturing and labeling violations, including undeclared shellfish allergens.
High risk -
DrugsFei Fah Medical Manufacturing Pte. Ltd.
FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.
High risk -
DrugsKobayashi Healthcare International, Inc.
Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.
High risk -
DrugsMohawk Laboratories Division of NCH Corporation
FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.
High risk -
DrugsUrban Electric Power
Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.
High risk -
DrugsBuzzagogo, LLC
Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.
High risk -
DrugsAuto-Chlor System LLC
Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.
High risk -
DrugsSuperior Glove Works, Ltd.
Canada's Superior Glove Works made hand sanitizers with ethanol containing unsafe acetaldehyde levels and skipped required testing, FDA says.
High risk -
DrugsGreen Pharmaceuticals Inc.
FDA found Green Pharmaceuticals' SnoreStop NasoSpray contaminated with Providencia rettgeri and sold as an unapproved new drug.
High risk -
DrugsMD Pharmaceutical Supply, LLC
FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.
High risk -
DrugsNortec Quimica SA
FDA warned Brazil's Nortec Quimica, an API maker, over deleted lab data and weak quality unit review of batches exported to the U.S.
High risk -
DrugsDuPont Nutrition USA Inc.
FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.
High risk -
DrugsSagent Pharmaceuticals, Inc.
FDA found SterRx, acquired by Sagent, made sterile drugs under conditions that risked contamination and lacked sterility assurance.
High risk -
DrugsCentrient Pharmaceuticals India Private Limited
Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.
High risk -
DrugsKari Gran Inc.
Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.
High risk -
DrugsAG Hair Limited
FDA warned AG Hair Limited over CGMP failures for hand sanitizer drugs, including inadequate investigations, microbiological controls, and component testing.
High risk -
DrugsGlenmark Pharmaceuticals Limited
FDA cited Glenmark's Goa plant for poor investigations, weak process validation, lab data controls, and incomplete batch records.
High risk -
DrugsShuzy Rock Inc.
FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.
High risk -
DrugsOmega & Delta Co., Inc.
FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.
High risk -
DrugsAbraxis Bioscience LLC
FDA warned Abraxis Bioscience about repeated contamination in media fills for sterile Abraxane at its Phoenix plant.
High risk -
DrugsNatureLab Corp.
FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.
Medium -
DrugsNephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, LLC
FDA warned Nephron Sterile Compounding Center about insanitary sterile drug production and sterility assurance failures found in a 2022 inspection.
High risk -
DrugsMcConnell Labs Inc.
McConnell Labs Inc. released hand sanitizers without raw material identity, finished product, or stability testing, FDA says.
High risk -
DrugsSovereign Pharmaceuticals, LLC
FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.
High risk -
DrugsLupin Limited
FDA warned Lupin Limited of current good manufacturing practice (CGMP) violations at its Tarapur API plant involving cleaning and genotoxic impurity controls.
High risk -
DrugsNephron SC Inc.
Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.
High risk